Expressions of Fas/DcR3 and RGD-FasL mediated apoptosis in pituitary adenomas

Neurology India

Volumn 57, Issue 1, 2009, Pages 28-30

  Chen, Lukui ^a   Tian, Xinhua ^a   Li, Wenzhu ^a   Agarwal, Abhishek ^b   Zhuang, Guohong ^a  

^a XIAMEN UNIVERSITY   (China)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Apoptosis; DcR3; Fas; Fasl; Pituitary adenoma; RGD FasL

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE; FAS ANTIGEN; FAS LIGAND; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHOTRANSFERASE; PROTEIN BCL 2; PROTEIN JNK2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; HYPOPHYSIS ADENOMA; NONHUMAN; PROTEIN EXPRESSION; RAT; TUMOR CELL;

ADENOMA; ANTIGENS, CD95; APOPTOSIS; CELL LINE, TUMOR; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; PITUITARY NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES;

EID: 63449088912     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.48808     Document Type: Article

References (4)

1. Jaita G, Candolfi M, Zaldivar V, Zarate S, Ferrari L, Pisera D, et al. Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes. Endocrinology 2005;146:4737-44.
2. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998;279:377-80.
3. Kobayashi H, Fukata J, Murakami N, Usui T, Ebisui O, Muro S, et al. Tumor necrosis factor receptors in the pituitary cells. Brain Res 1997;758:45-50.
4. Huang P, Tofighi R, Emgard M, Ceccatelli S. Cell death induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) in AtT-20 pituitary cells. Toxicology 2005;207:391-9.